Intellia Therapeutics (NTLA) EBIT (2015 - 2026)
Intellia Therapeutics' EBIT came in at -$112.76 million for Q2 2026, compared with -$110 million a year earlier.
Powered by 
Analysis
Intellia Therapeutics (NTLA) EBIT (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Intellia Therapeutics reported EBIT of -$423.48 million; for FY2025, it came in at -$440.99 million.
- Going back by year, EBIT was -$534.26 million in FY2024, -$515.29 million in FY2023, -$458.16 million in FY2022 and -$267.85 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly EBIT since Q1 2025.
- Business Quant data shows NTLA's EBIT at -$100.53 million (Q1 2026), -$98.71 million (Q4 2025) and -$111.48 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Intellia Therapeutics | 1.60 Bn | 1.60 Bn | - | -112.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -112.76 Mn |
| Mar 31, 2026 | -100.53 Mn |
| Dec 31, 2025 | -98.71 Mn |
| Sep 30, 2025 | -111.48 Mn |
| Jun 30, 2025 | -110.00 Mn |
| Mar 31, 2025 | -120.81 Mn |
| Dec 31, 2024 | -136.45 Mn |
| Sep 30, 2024 | -144.77 Mn |
| Jun 30, 2024 | -139.04 Mn |
| Mar 31, 2024 | -114.00 Mn |
| Dec 31, 2023 | -139.89 Mn |
| Sep 30, 2023 | -131.11 Mn |
| Jun 30, 2023 | -132.33 Mn |
| Mar 31, 2023 | -111.96 Mn |
| Dec 31, 2022 | -110.09 Mn |
| Sep 30, 2022 | -105.53 Mn |
| Jun 30, 2022 | -98.30 Mn |
| Mar 31, 2022 | -144.25 Mn |
| Dec 31, 2021 | -80.42 Mn |
| Sep 30, 2021 | -71.99 Mn |
API Access
Intellia Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();